Loading...
Chemical structure of BIIB091

GC63846

BIIB091

Also known as 1-tert-butyl-N-[(5R)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-2-(oxetan-3-yl)-1,3,4,5-tetrahydro-2-benzazepin-5-yl]triazole-4-carboxamide

BIIB091 is a highly selective, reversible and orally active BTK inhibitor for treating autoimmune diseases

ChemicalCAS2247614-80-6MW542.64FormulaC28H34N10O2
CAS number
2247614-80-6
Molecular weight
542.64
Formula
C28H34N10O2
InChIKey
JSAQBOQCZJHWMA-XMMPIXPASA-N
Catalogue number
GC63846
Brand
GLPBIO
Computed properties PubChem CID 135355941 · XLogP 1.5 · TPSA 128 Ų · H-bond donors 2
XLogP
1.5
TPSA
128 Ų
H-bond donors
2
H-bond acceptors
9
Rotatable bonds
7
Heavy atoms
40

SMILES CC(C)(C)N1C=C(N=N1)C(=O)N[C@@H]2CCN(CC3=C2C=CC(=C3)C4=NC(=NC=C4)NC5=CN(N=C5)C)C6COC6

Computed descriptors from PubChem (CID 135355941), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.